NantHealth, the healthcare subsidiary of US-based computing technology developer NantWorks, closed a $320m series B round last week after receiving a $250m investment from sovereign wealth fund Kuwait Investment Authority (KIA).
The funding came less than four months after NantHealth secured $25m from pharmaceutical company Celgene and roughly six months after KIA invested $100m, though it is unclear whether any of KIA’s previous funds contributed to the $320m figure.
NantHealth is developing a healthcare management system that will combine molecular science, patient signal monitoring, computer science and big data to help healthcare providers make real-time care decisions.
Steve Curd, NantHealth’s newly installed chief operating officer, said: “NantHealth’s goal is nothing less than transforming healthcare, knocking down the traditional barriers of today’s soiled system by enabling providers to make complex treatment decisions with all available medical information in a single location.
“I am tremendously excited to be a part of this visionary company during this pivotal time of structural change happening in the provision of care in our country today.”
The company’s other backers include Verizon Ventures, which is telecommunications company Verizon’s corporate venturing unit, and smartphone manufacturer Blackberry.